Pneumococcal vaccination for welders: Global deployment within a multi-national corporation.

Autor: Donoghue AM; Alcoa Alumina, Applecross, Perth, Western Australia, Australia., Wesdock JC; Alcoa Corporation, Pittsburgh, Pennsylvania.
Jazyk: angličtina
Zdroj: American journal of industrial medicine [Am J Ind Med] 2019 Jan; Vol. 62 (1), pp. 69-73. Date of Electronic Publication: 2018 Dec 10.
DOI: 10.1002/ajim.22934
Abstrakt: Background: Lobar pneumonia is an occupational disease of welders. This is the first report of global deployment of a pneumococcal vaccination program for welders within a multi-national corporation.
Methods: Global webinars were conducted to introduce the program. Communication packages translated into all location languages were deployed. All employee welders who had not previously been vaccinated were offered a free single dose of pneumococcal polysaccharide vaccine (PPV23) by on-site location medical centers during normal working hours. Numbers of vaccinated welders were reported by each location each month.
Results: Twelve months after starting the program, 241 of 767 welders have been vaccinated (31%) across six countries.
Conclusions: Global deployment of pneumococcal vaccination for welders can be successfully undertaken by a multi-national corporation. Adoption of this practice by corporations could reduce the incidence and mortality of pneumonia among welders globally.
(© 2018 The Authors. American Journal of Industrial Medicine Published by Wiley Periodicals, Inc.)
Databáze: MEDLINE
Externí odkaz: